biotech · Pediatric acute-onset neuropsychiatric syndrome (PANS) · acute hereditary angioedema attacks · MAZE
Maze Therapeutics
Maze Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
South San Francisco, USA HQ
2018 Founded
152 Employees
Public company Type
MAZE · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2018
- Employees
- 152
- Programs
- 8
- Drugs
- 12
- Patents
- 60
Maze Therapeutics clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Maze Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Maze Therapeutics trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Maze Therapeutics.
Trial registry
-
CTIS ↗ - 2023-509737-39-00CTIS ↗
NGAM-12
Primary infection prophylaxis in patients with chronic lymphocytic leukemia (CLL) and secondary hypogammaglobulinemia.
-
CTIS ↗ -
CTIS ↗ -
CTIS ↗ - 2025-522854-37-00CTIS ↗
NGAM-16
Prevention of a Major infection in patients with Hypogammaglobulinemia and Autoimmune or Rheumatic Conditions receiving treatment with B-cell depletion therapy.
-
CT.gov ↗ -
CT.gov ↗